[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @anexpertone AnExpertOne AnExpertOne posts on X about $pgen, $ntla, $125m, $adap the most. They currently have XX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1951734368944480256/interactions)  - X Week XXXXX -XX% - X Month XXXXXX -XX% ### Mentions: X [#](/creator/twitter::1951734368944480256/posts_active)  - X Week XX -X% - X Month XX -XXXX% ### Followers: XX [#](/creator/twitter::1951734368944480256/followers)  - X Week XX +20% - X Month XX +48% ### CreatorRank: undefined [#](/creator/twitter::1951734368944480256/influencer_rank)  ### Social Influence [#](/creator/twitter::1951734368944480256/influence) --- **Social topic influence** [$pgen](/topic/$pgen) #14, [$ntla](/topic/$ntla) 5%, [$125m](/topic/$125m) 5%, [$adap](/topic/$adap) 5%, [pumper](/topic/pumper) X% **Top accounts mentioned or mentioned by** [@steptradez](/creator/undefined) [@investrch](/creator/undefined) [@shortsellerst](/creator/undefined) [@amaymd](/creator/undefined) [@geneinvesting](/creator/undefined) [@invest_rch](/creator/undefined) **Top assets mentioned** [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) ### Top Social Posts [#](/creator/twitter::1951734368944480256/posts) --- Top posts by engagements in the last XX hours "Very nice Did I call it (similar) or what.ha. $PGEN" [X Link](https://x.com/anexpertone/status/1977728722967941308) [@anexpertone](/creator/x/anexpertone) 2025-10-13T13:30Z XX followers, XXX engagements "$PGEN Great DATA - yet peon brain(s) took back over. From Precigen Key data highlights from the AAO-HNSF presentation: XX out of the XX complete responders (83%) in the pivotal study demonstrated ongoing complete responses as of the September XX 2025 data cutoff with: Median duration of follow-up of XX months (range: 27-37 months); Median duration of complete response yet to be reached; and No new safety events observed during long-term follow-up. Prolonged reduction in the requirement for surgical intervention to manage RRP was observed throughout long-term follow-up of evaluable study" [X Link](https://x.com/anexpertone/status/1977741164301230553) [@anexpertone](/creator/x/anexpertone) 2025-10-13T14:20Z XX followers, XXX engagements "MM's eating up them Calls expiring this OE Week but of course Maybe we get 'more' good news via $PGEN this week (like what occured in August) if only.ha. 1) News that the Tx Launch is going well. 2) Some Pharma views Precigen as too cheap - wants a piece of the Pie or the Whole - would be nice but oh I know likely not so soon" [X Link](https://x.com/anexpertone/status/1977773917851836704) [@anexpertone](/creator/x/anexpertone) 2025-10-13T16:30Z XX followers, XXX engagements "Other than it being OE week why the dummy-dump down Only seeing some dumping of OCT calls/Puts expiring on Friday this week. They likely pivot & buy more NOV calls soon I bet $NTLA" [X Link](https://x.com/anexpertone/status/1977792220993646698) [@anexpertone](/creator/x/anexpertone) 2025-10-13T17:43Z XX followers, XXX engagements "Very good on $PGEN The FDA approved Papzimeos early with a broader label than expected. When we did the deal in Dec the stock was around $XXXX. It ended July at $XXXX and surged to over $X after approval. Its since pulled back to a low of $XXXX on par with historical post-approval pullbacks. In September the company raised a $125M credit facility which gives them time to commercialize Papzimeous a process thats fraught with risk and delays. Since the papillomatosis patient population is in dire need with no other treatment options theres a high incentive for providers and payers to work" [X Link](https://x.com/anexpertone/status/1978444129764880403) [@anexpertone](/creator/x/anexpertone) 2025-10-15T12:53Z XX followers, XXX engagements "$PGEN Nice strong close near HOD - think I sold a few calls to a Huge buyer of" [X Link](https://x.com/anexpertone/status/1979301735853363225) [@anexpertone](/creator/x/anexpertone) 2025-10-17T21:41Z XX followers, XXX engagements "$ADAP Wow nutty as hell why they never wanted to reverse split is so bizarre Been tons of highly followed *Pumper* Traders touting this as a Team of late. Where did they all go now LOL 🤣 🤡's But anyway once again did not see this coming. Some VERY Bad management there in UK" [X Link](https://x.com/anexpertone/status/1980262744298275093) [@anexpertone](/creator/x/anexpertone) 2025-10-20T13:20Z XX followers, 1041 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@anexpertone AnExpertOne
AnExpertOne posts on X about $pgen, $ntla, $125m, $adap the most. They currently have XX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX -XX%
- X Month XXXXXX -XX%
Mentions: X #
- X Week XX -X%
- X Month XX -XXXX%
Followers: XX #
- X Week XX +20%
- X Month XX +48%
CreatorRank: undefined #
Social Influence #
Social topic influence $pgen #14, $ntla 5%, $125m 5%, $adap 5%, pumper X%
Top accounts mentioned or mentioned by @steptradez @investrch @shortsellerst @amaymd @geneinvesting @invest_rch
Top assets mentioned Intellia Therapeutics, Inc (NTLA)
Top Social Posts #
Top posts by engagements in the last XX hours
"Very nice Did I call it (similar) or what.ha. $PGEN"
X Link @anexpertone 2025-10-13T13:30Z XX followers, XXX engagements
"$PGEN Great DATA - yet peon brain(s) took back over. From Precigen Key data highlights from the AAO-HNSF presentation: XX out of the XX complete responders (83%) in the pivotal study demonstrated ongoing complete responses as of the September XX 2025 data cutoff with: Median duration of follow-up of XX months (range: 27-37 months); Median duration of complete response yet to be reached; and No new safety events observed during long-term follow-up. Prolonged reduction in the requirement for surgical intervention to manage RRP was observed throughout long-term follow-up of evaluable study"
X Link @anexpertone 2025-10-13T14:20Z XX followers, XXX engagements
"MM's eating up them Calls expiring this OE Week but of course Maybe we get 'more' good news via $PGEN this week (like what occured in August) if only.ha. 1) News that the Tx Launch is going well. 2) Some Pharma views Precigen as too cheap - wants a piece of the Pie or the Whole - would be nice but oh I know likely not so soon"
X Link @anexpertone 2025-10-13T16:30Z XX followers, XXX engagements
"Other than it being OE week why the dummy-dump down Only seeing some dumping of OCT calls/Puts expiring on Friday this week. They likely pivot & buy more NOV calls soon I bet $NTLA"
X Link @anexpertone 2025-10-13T17:43Z XX followers, XXX engagements
"Very good on $PGEN The FDA approved Papzimeos early with a broader label than expected. When we did the deal in Dec the stock was around $XXXX. It ended July at $XXXX and surged to over $X after approval. Its since pulled back to a low of $XXXX on par with historical post-approval pullbacks. In September the company raised a $125M credit facility which gives them time to commercialize Papzimeous a process thats fraught with risk and delays. Since the papillomatosis patient population is in dire need with no other treatment options theres a high incentive for providers and payers to work"
X Link @anexpertone 2025-10-15T12:53Z XX followers, XXX engagements
"$PGEN Nice strong close near HOD - think I sold a few calls to a Huge buyer of"
X Link @anexpertone 2025-10-17T21:41Z XX followers, XXX engagements
"$ADAP Wow nutty as hell why they never wanted to reverse split is so bizarre Been tons of highly followed Pumper Traders touting this as a Team of late. Where did they all go now LOL 🤣 🤡's But anyway once again did not see this coming. Some VERY Bad management there in UK"
X Link @anexpertone 2025-10-20T13:20Z XX followers, 1041 engagements